News Detail
Lucknow, 6 Jan 2025: In a ray of hope for patients of triple negative breast cancer (TNBC), the scientists have found that administration of a drug on a specific enzyme found in the human body can help treat this most aggressive subtype of breast cancer.
"A......
View Details
Source : The Times of India
CSIR-Central Drug Research Institute
triple negative breast cancer
CDRI research
breast cancer treatment
ACSL4 enzyme
TNBC treatment
cancer metastasis
breast cancer research
new therapeutic strategies
Related News
- Sun Pharma unit Taro to acquire 100% stake in Antibe Therapeutics (16-01-2025)
- Calcutta HC directs Paschim Banga Pharmaceuticals to stop manufacturing; state to compensate families (16-01-2025)
- FDA Revokes Use of 'FD&C Red No.3' in Foods and Drugs (16-01-2025)
- Dabur sues Patanjali over toothpaste trade dress (16-01-2025)
- Wrappers of drug brands found from Paonta printing press premises (16-01-2025)
- PCI revises list of pharmacists blocked on DIGI-PHARMed platform, asks to re-register (16-01-2025)
- Clear labelling of industrial & medical oxygen must, PMO tells health ministry (16-01-2025)
- Himachal to form Special Task Force to Combat Drug Abuse (16-01-2025)
- SC warns States/UTs of Contempt Proceedings over inaction on Misleading Advertisements (16-01-2025)
- 3600 Proxyvon capsule consignment going to Nepal caught (15-01-2025)